Table 2.
Laboratory parameters of mCRPC studied patients before and after 3 cycles of PSMA-RLT at 4 weekly intervals
| Parameters | Before therapy | After therapy | P value |
|---|---|---|---|
| *PSA μg/L | 66 (1.0–4890) | 19.8 (0.7–4563) | < 0.001 |
| Hemoglobin g/dL (mean ± SD) | 11.7 ± 1.9 | 11.4 ± 1.9 | NS |
| Thrombocytes g/L (mean ± SD) | 236 ± 71 | 193 ± 67 | < 0.001 |
| *Leucocytes g/L | 6.5 (2.9–13.7) | 4.8 (1.5–12.3) | < 0.001 |
| *Creatinine mg/dL | 0.9 (0.6–1.6) | 0.86 (0.6–1.8) | NS |
| *Alkaline phosphatase U/L (mean ± SD) | 66 (27–469) | 68 (27–580) | NS |
| *LDH (mean ± SD) U/L | 189 (136–620) | 197 (125–323) | NS |
*Data with no Gaussian distribution, presented in median (range) and log10-transformd for analysis. NS not significant. P < 0.05 = statically significant